Resources Management Corp’s Clovis Oncology, Inc. CLVS Stock Holding History

Resources Management Corp’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,795	Closed	-$518K	–	485
2023 Q1	$518K	Buy	16,795 +16,545	+6,618%	+$510K	0.08%	150
2022 Q4	$0	Hold	250	–	–	﹤0.01%	488
2022 Q3	$0	Hold	250	–	–	﹤0.01%	515
2022 Q2	$0	Hold	250	–	–	﹤0.01%	523
2022 Q1	$1K	Hold	250	–	–	﹤0.01%	489
2021 Q4	$1K	Hold	250	–	–	﹤0.01%	499
2021 Q3	$1K	Hold	250	–	–	﹤0.01%	476
2021 Q2	$1K	Hold	250	–	–	﹤0.01%	483
2021 Q1	$2K	Hold	250	–	–	﹤0.01%	483
2020 Q4	$1K	Hold	250	–	–	﹤0.01%	479
2020 Q3	$1K	Hold	250	–	–	﹤0.01%	435
2020 Q2	$2K	Hold	250	–	–	﹤0.01%	459
2020 Q1	$2K	Hold	250	–	–	﹤0.01%	460
2019 Q4	$3K	Hold	250	–	–	﹤0.01%	433
2019 Q3	$1K	Buy	+250	New	+$2.02K	﹤0.01%	498
2018 Q4	$4K	Hold	250	–	–	﹤0.01%	448
2018 Q3	$7K	Buy	+250	New	+$9.68K	﹤0.01%	398

Resources Management Corp's CLVS Position: Q2 2023 in Review

Resources Management Corp sold out of Clovis Oncology, Inc. (CLVS) in Q2 2023, closing a stake of 16,795 shares — an estimated $518K sold.

Resources Management Corp first reported a position in CLVS in Q3 2018 and held it in 17 quarters. The position peaked at $518K in Q1 2023. 0 funds tracked by Wall St. Rank hold CLVS as of Q2 2023.

Resources Management Corp reported no remaining Clovis Oncology, Inc. position as of Q2 2023 after selling out during the quarter.
Resources Management Corp sold 16,795 Clovis Oncology, Inc. shares in Q2 2023, an estimated $518K.
Resources Management Corp first reported a position in Clovis Oncology, Inc. in Q3 2018 and held it in 17 quarters.
Resources Management Corp's Clovis Oncology, Inc. position peaked at $518K in Q1 2023.
0 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2023.

Based on Resources Management Corp's 13F filing for Q2 2023, filed 16 Aug 2023.